Abstract:Objective: To study the effects of tanshinone ⅡA(Tan ⅡA) in ameliorating hepatic ischemia reperfusion(IR) injury and its mechanisms in vivo.Methods: C57BL/6 Mice were randomized into five groups: group A that mice received sham operation,group B that mice underwent 90 min liver lobes ischemia then reperfusion,group C that mice were pretreated with DMSO before IR operation,group D and E that mice were pretreated with different doses of tanshinone ⅡA three days before IR operation.The blood and liver samples were collected after 6 hours' reperfusion.The levels of ALT and AST were determined to evaluate the pathological injury of liver.The expressions of HO-1 and TLR4,signal protein phosphorylation and inflammatory cytokines in liver were detected by Real-time PCR and Western-blot.Results: The levels of ALT,AST and IL-6 in group A were lower and the structure of liver was normal.The levels of ALT,AST and IL-6 in group B increased significantly compared with group A(P<0.01) and pathological injury of liver was serious.The levels of ALT and AST in group D and E decreased obviously compared with group B and C,and the pathological injury of liver was lighter;the expressions of TNF-α,IL-6,IL-1β and MCP-1 markedly decreased,the expression of TLR4 and the phosphorylation of JNK and p65 were inhibited,the expression of HO-1 was promoted in both group D and E,the effects of group E were more obviously than group D.Conclusion: The pretreatment of Tan Ⅱ A can inhibit the expression of TLR4 and induce the expression of HO-1,and further inhibit the inflammatory signal activation and alleviate the ischemia reperfusion injury.

Effects of Tanshinone ⅡA in Ameliorating Hepatic Ischemia Reperfusion Injury and Its Molecular Mechanisms